Condition

Metastatic Non-Squamous Non-Small Cell Lung Cancer clinical trials and research

• 5Clinical trials
• 8Countries

Newest Metastatic Non-Squamous Non-Small Cell Lung Cancer clinical trials

All recruiting trials (5)

• First-line treatment with pembrolizumab, pemetrexed, and platinum with or without zoldonrasib for metastatic non-squamous NSCLC

  This trial tests whether adding zoldonrasib to standard pembrolizumab and platinum chemotherapy helps people with untreated metastatic non-squamous NSCLC that has a RAS G12D mutation.

  Recruiting at 4 sites Phase 3 Revolution Medicines, Inc. · Anchorage, Alaska and 3 other locations · NCT07777822

• Visugromab plus nivolumab, with or without docetaxel, for second-line treatment of metastatic non-squamous non-small cell lung cancer

  This trial tests whether adding the anti-GDF-15 antibody visugromab to nivolumab, with or without docetaxel, helps people with metastatic non-squamous NSCLC whose cancer progressed after first-line treatment that included a checkpoint inhibitor.

  Recruiting at 36 sites Phase 2 CatalYm GmbH · Birmingham, Alabama and 35 other locations · NCT07246863

• Visugromab added to first-line immunochemotherapy for metastatic non-squamous NSCLC

  This trial tests whether adding visugromab to standard immunochemotherapy (pembrolizumab, pemetrexed, carboplatin) helps people with newly diagnosed metastatic non-squamous NSCLC who do not have targetable mutations.

  Recruiting at 51 sites Phase 2 CatalYm GmbH · Birmingham, Alabama and 50 other locations · NCT07098988

• New treatment for advanced non-small-cell lung cancer using a virus and chemotherapy

  This study is testing a new treatment that combines a special virus and chemotherapy to see if it can help people with advanced lung cancer who haven't responded to previous treatments.

  Recruiting at 15 sites Phase 2 Genelux Corporation · Bullhead City, Arizona and 14 other locations · NCT06463665

• Combining JAB-21822 and JAB-3312 for advanced lung cancer with KRAS mutation

  This study is testing if a new combination of JAB-21822 and JAB-3312 can help people with advanced lung cancer that has a specific KRAS mutation do better than the usual treatment.

  Recruiting at 6 sites Phase 3 Allist Pharmaceuticals, Inc. · Hefei, Anhui and 36 other locations · NCT06416410

Related topics

Quick answers

How many Metastatic Non-Squamous Non-Small Cell Lung Cancer clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (4 trials), Germany (2 trials), Italy (2 trials), Poland (2 trials), Romania (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →